News
-
A group of researchers funded by the Research Institute for Fragrance Materials (RIFM) have developed a new model for vapor deposition in the lung and have published their work in an article titled “Derivation of… Read more . . .
-
An editorial by Monica Kraft in the August 31 online version of the New England Journal of Medicine voices approval for a recent article in the journal describing a study of lebrikizumab treatment for asthma… Read more . . .
-
According to the FDA’s latest update on the ongoing acetylcysteine inhalation solution shortage, all of American Regent/Luitpold’s product is still on back order due to “manufacturing delays,” and the company is still unable to estimate… Read more . . .
-
A randomized, double-blind, Phase 2b dose-ranging study of Pearl Therapeutics’ formoterol fumarate MDI compared to Foradil Aerolizer and placebo showed statistically significant benefits in patients with moderate-to-severe COPD, according to the company. The metered dose… Read more . . .
-
Contract research company Gateway Analytical has received certification under ISO standard 9001:2008 for its analytical laboratory process quality management system. The laboratory, which provides ingredient-specific particle sizing for nasal sprays and inhalers among other services,… Read more . . .
-
The United States Court of Appeals has upheld a patent for Fortical calcitonin nasal spray held by Unigene Laboratories. Fortical, a bioequivalent of Novartis’s Miacalcin, is marketed in the US by Unigene subsidiary Upsher-Smith for… Read more . . .
-
A randomized, double-blind study conducted by researchers from the University of Cincinnati has shown that a capsaicin nasal spray available over the counter significantly relieved nasal congestion, sinus pain, sinus pressure, and headache in patients… Read more . . .
-
British biopharmaceutical company Lightlake Therapeutics has announced that it will begin Phase 2 trials of its naloxone nasal spray for the treatment of binge eating disorder in overweight and obese patients on August 26th, 2011… Read more . . .
-
A study by University of Washington researchers published in the September 2011 issue of Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, demonstrates improved delivery of morphine and fentanyl in rats… Read more . . .
-
Physical Properties Scientist, GlaxoSmithKline, Ware, Hertfordshire Basic qualifications: Extensive experience in pharmaceutical development, and physical property characterisation. A good knowledge of analytical techniques relating to solid state and powder properties and the ability to work… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan